Marshall Wace
CVS icon

Marshall Wace’s CVS Health CVS Stock Holding History

Marshall Wace’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.4K Buy
+700
New +$62.5K ﹤0.01% 2956
2023
Q3 		– Sell
-19,600
Closed -$1.35M – 2277
2023
Q2 		$1.35M Buy
+19,600
New +$1.39M ﹤0.01% 1600
2023
Q1 		– Sell
-32,500
Closed -$3.03M – 2745
2022
Q4 		$3.03M Buy
+32,500
New +$3.14M 0.01% 1503
2021
Q2 		– Sell
-3,000
Closed -$226K – 2721
2021
Q1 		$226K Buy
+3,000
New +$219K ﹤0.01% 2219

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Marshall Wace's CVS Position: Q2 2026 in Review

Marshall Wace reduced its CVS Health (CVS) stake by 60% in Q2 2026, selling an estimated $43.1M and leaving 325,000 shares worth $33.6M. The position accounts for 0.03% of the portfolio, ranked #513.

Marshall Wace first reported a position in CVS in Q2 2014 and has held it in 45 quarters since. The position peaked at $383M in Q4 2023. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Marshall Wace held 325,000 shares of CVS Health worth $33.6M as of Q2 2026.
  • Marshall Wace sold 482,534 CVS Health shares in Q2 2026, an estimated $43.1M.
  • CVS Health made up 0.03% of Marshall Wace's portfolio in Q2 2026, its #513 holding.
  • Marshall Wace first reported a position in CVS Health in Q2 2014 and has held it in 45 quarters since.
  • Marshall Wace's CVS Health position peaked at $383M in Q4 2023.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.